CRNX icon

Crinetics Pharmaceuticals

61 hedge funds and large institutions have $229M invested in Crinetics Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 21 increasing their positions, 17 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
61
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$2.57M
2 +$2.18M
3 +$2.15M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$1.99M
5
Millennium Management
Millennium Management
New York
+$829K

Top Sellers

1 -$84.4M
2 -$12.3M
3 -$6.55M
4
Goldman Sachs
Goldman Sachs
New York
-$1.63M
5
MWNA
Marshall Wace North America
New York
-$1.08M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$54.5M
2
$38.9M
3
$30.7M
4
$28.2M
5
$14.5M
6
$14.2M
7
$7.58M
8
$7.47M
9
$3.22M
10
$3.11M
11
$3.1M
12
$2.63M
13
$2.12M
14
$2.04M
15
$2.03M
16
$1.99M
17
$1.83M
18
$1.36M
19
$1.09M
20
$829K
21
$829K
22
$786K
23
$768K
24
$725K
25
$521K